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Objective: Functional tissue engineering has emerged as a potential means for treatment of cartilage defect.
Development of a stable cartilage composite is considered to be a good option. The aim of the study was to
observe whether the incorporation of cultured chondrocytes on porous tantalum utilizing fibrin as a cell carrier
would promote cartilage tissue formation.
Methods: Rabbit articular chondrocytes were cultured and seeded onto tantalum with fibrin as temporary matrix in
a composite, which was divided into three groups. The first group was kept in vitro while a total of 12 constructs
were implanted into the dorsum of mice for the second and third groups. The implanted tissues were harvested
after 4 weeks (second group) and after 8 weeks (third group). Specific characteristic of cartilage growth were
studied by histological and biochemical assessment, immunohistochemistry, and quantitative PCR analysis.
Results: Histological and biochemical evaluation of the formed cartilage using hematoxylin and eosin and Alcian
blue staining showed lacunae chondrocytes embedded in the proteoglycan rich matrix. Dimethylmethylene blue
assay demonstrated high glycosaminoglycans content in the removed tissue following 8 weeks of implantation.
Immunohistochemistry results showed the composites after implantation expressed high collagen type II.
Quantitative PCR results confirmed a significant increase in cartilage associated genes expression (collagen type II,
AggC, Sox 9) after implantation.
Conclusion: Tantalum scaffold with fibrin as cell carrier promotes chondrocyte proliferation and cartilaginous tissue
formation. Producing hyaline cartilage within a stable construct of tantalum and fibrin has a potential for treatment
of cartilage defect.
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Around two million individuals are affected worldwide
with arthritis [1]. These individuals require hospitalization,
which is a matter of concern. Total joint replacement is
the usual end-stage treatment, but implant longevity is an
issue as more than half of the affected individuals is below
65 years old [2-7]. Damage to articular cartilage leads to
premature arthritis. This chondral lesion was reported to
be present in 60% of all patients aged between 40–50 years
during arthroscopy [1,7,8]. Due to its avascular nature and* Correspondence: drkortho@gmail.com
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potential to heal, even so in larger defects. Partial thickness
injuries do not heal and merely stimulate minimal reaction
to adjacent chondrocytes in the form of cell replication and
matrix turnover, whereas full thickness injuries penetrating
subchondral bone produce normal healing response but
eventually fills the defect with fibrocartilage [9]. Fibrocarti-
lage resists to tension, in contrast to normal hyaline cartil-
age which resists compressive forces. Therefore, there is an
urgent need for a method for effective biological healing
and regeneration of cartilage to prevent premature arthritis.
There are various methods of operative treatment
employed to treat osteochondral injury. Marrow stimula-
tion and resurfacing techniques have been advocated buthis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Tantalum scaffold in 10 mm in diameter and 0.5 mm
in thickness.
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fects and producing hyaline cartilage [9-15]. Autologous
chondrocyte implantation (ACI) which was brought into
attention by Brittberg et al. in 1994 is quite promising
but this technique is expensive and highly technically
dependent [10]. It requires two surgeries and needs la-
boratory support to grow the cells [13].
Functional tissue engineering is a novel approach to
enhance tissue regeneration and provides the possibility
of producing tissue that is biomechanically, biochemically,
and histomorphologically similar to the native tissues [7].
Scientists and engineers working in this promising field
are taking steps to make those ideas a reality, working to
supply biological substitutes or living tissue. A previous
study by Munirah et al. for articular cartilage restoration
focused on engineering autologous cartilage construct
using human and ovine chondrocytes incorporated with
the autologous fibrin as biomaterial [16]. The pre-clinical
study, conducted in sheep, was designed to evaluate the
performance of the autologous ‘chondrocytes-fibrin’ con-
struct implantation in a simulated clinical application
prior to undertaking the definitive pre-clinical and clinical
investigations. However, it has its own limitation. Resulted
‘chondrocytes-fibrin’ constructs were too soft to hold into
the defect independently. Technically, periosteal patch
were used to secure the implant into the defect.
There is continuous quest for the development of a
new and more reliable technique to restore or recon-
struct osteochondral defects. The development of a
composite with the biochemical and mechanical proper-
ties of an osteochondral graft with better integration
properties and without the need for autologous osteo-
chondral graft harvesting or allogeneic tissue would be
attractive. Tantalum, an elemental metal which is strong,
biocompatible, and corrosive-resistant, has been widely
used in the field of orthopedics due to its low modulus
of elasticity and low frictional characteristics. It also has
high, interconnected porosity with excellent bone in
growth properties. In the present study, we incorporated
cultured chondrocytes on porous tantalum utilizing fi-
brin as a cell carrier to support in vitro chondrogenesis.
Following this, we compared it with constructs im-
planted for 4 and 8 weeks, which hypothetically has su-
perior cartilaginous development.
Materials and methods
The study was conducted after receiving the ethical ap-
proval from the animal and research ethics committee of
our university. The project approval number from
Universiti Kebangsaan Malaysia was FF-307-2009.
Tantalum preparation
All scaffolds were prepared from 2 cm in diameter and
10 cm length of Zimmer tantalum screw using MachineWire Cut (Hitachi, H-Cut 203 M20) in thickness of
0.5 mm and Milling Machine Cut to make holes Ø1.0
on the both surface of tantalum (Figure 1).
Chondrocyte cell preparation
Six New Zealand white rabbits age 2 months old and
weighting 2.0–2.3 kilograms were used as experimental
animals. Blood was taken to get autologous plasma and
serum before the animal was sacrificed with overdosage
of phenobarbital. Full-thickness cartilage was harvested
from the knee, hip joints, and patella articular surface
under aseptic technique. Each cartilage was separated
from the perichondrium and subchondrium bone,
minced into small pieces (1 mm3), washed with Dul-
becco phosphate buffer saline (DPBS; pH 7.2; Gibco,
Grand Island, NY, USA) containing 100 μ/ml penicillin
and 100 μ/ml streptomycin (PBS, Gibco). Finally, the
samples were washed with DPBS one more time. Carti-
lages were digested using 0.3% collagenase type II (Gibco)
in a shaker incubator (Stuart Scientific, Redhill, UK) at 37°C
for 90 min. Samples were centrifuged (500 × g) for 10 min
to get the cell pellet. The supernatant was removed and the
cell pellet was washed with 15 ml DPBS to remove the
remaining enzyme. The sample was centrifuged for 10 min
to get the final pellet cells. Isolated chondrocytes were
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(Ham’s F12 and Dulbecco’s modified medium 1:1 + 1% as-
corbic acid + 10% autologous serum+ antibiotic/antimyco-
tic + 1% glutamine). All cultures were maintained in 5%
CO2 incubator (Jouan, Duguay, Trouin, SH) at 37°C with
every 3 days medium change. Once confluence, the primary
cultures were trypsinized using trypsin-EDTA 0.125%
(Gibco). The cells pellet were then cultured in large-scale
175 cm2 culture flask (Falkon, Franklin Lake, NJ, USA) at a
density of 5,000 cells/cm2. Chondrocyte morphologic fea-
tures were examined every day using inverted light micro-
scope (Olympus, Shinjukuku, Tokyo). Upon confluence, the
cells were trypsinized and mix with plasma before put on to
the tantalum. Fibrin polymerization took place after CaCl2
solution was added into the mixture. The cell-fibrin-
tantalum constructs were maintained for 3 days in the cul-
ture before implantation. It was cultured in the same
medium for cell expansion, in the six-well dishes and main-
tained in the CO2 incubator.Construct implantation
Under aseptic technique, surgery was performed under
sedation. Cocktail drug which consist of ketamine, xyla-
zine, and zoletil was given according to body weight
intramuscular. Surgical incision was made at the dorsum
of nude mice, and two constructs were implanted on the
left and right side of the dorsum (Figure 2). The skin
was then sutured using 6/0 vicryl (12 complexes totally
at six mice). Care of the nude mice was carried out follow-
ing the animal facility guideline of the Animal Unit, UKM.Harvest of composite
Three mice were sacrificed after 4 weeks and another
three mice were sacrificed after 8 weeks to remove the
constructs.Figure 2 Construct implanted over dorsum of mice.Histological and biochemical assessment
The obtained cartilage underwent histology and bio-
chemical evaluation. Constructs were fixed in 10% for-
malin for 24 h at 4°C and processed using standard
histological technique which finally embedded in paraf-
fin. The tissues were cross sectioned (5 μm thick) and
stained with hematoxylin and eosin, and Alcian blue ac-
cording to standard procedures. For biochemical assess-
ment, the amount of glucosaminoglycans (GAGs) was
measured using the dimethylmethylene blue (DMMB)
assay (12) and the total amount of GAGs per dry weight
of formed cartilage (μg/ml/mg) was recorded.
GAG quantification
For quantitative measuring of GAGs, the total GAGs
content of cell/polymer constructs was determined using
papain digestion and the dimethylmethylene blue dye
method. Samples were lyophilized for 24 h and then
digested under sterile conditions with papain type III
(Sigma) at 125 mg/ml in a buffer of 0.1 M NaH2PO4,
5 mM methylenediaminetetraacetic acid, and 5 mM
cysteine hydrochloride at pH 7.0 overnight at 60°C be-
fore the dye was added. Dimethylmethylene blue stock
solution was made using dimethylmethylene blue, sodium
chloride, glycine, sodium aziade in 1 N hydrochloride, and
water. A spectrophotometer set at a wavelength of 520 nm
was used to measure the optical density of the digested
samples. Glycosaminoglycan was measured and reported
in micrograms per milliliter per milligram of dry weight
tissue.
Immunohistochemistry
Formalin-fixed tissues were sectioned and treated with
proteinase K at 37°C for 60 min before washed three
times with tris buffered saline (TBS, DAKO Cytoma-
tion). The sections were then treated with peroxidase
block at 37°C for 10 min prior to incubation with anti-
body. Two antibodies were used, anti-type I and anti-
type II collagen were diluted 1:150 with diluent (DAKO
Cytomation) and applied to different sections for 40 min
at 37°C. After washing with TBS, the sections were
reacted with horseradish peroxidase (HRP) for 40 min at
37°C. After washing again with TBS, the signal was fi-
nally visualized as a brown reaction product from the
peroxidase substrate 3,3′-diaminobenzidine (DAB).
Quantitative gene expression by real-time PCR
Total RNA was extracted from removed tissue engineered
using TRI reagent (Molecular Research Center, Cincinnati)
according to the manufacturer. Cartilage differentiation
(type II collagen, SOX9 transcription factor, and aggrecan
core protein), dedifferentiation (type I collagen), and hyper-
trophy (type X collagen) gene expression level was quanti-
fied by real-time PCR technique. Primer sequence used was
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database sequences corresponding to the specific gene Ac-
cession Number. The reaction kinetic and specificity of
each primer set was verified with standard curve and melt-
ing profile. The quantitative RT-PCR protocol was per-
formed in a Bio-Rad iCycler with profile of cDNA synthesis
for 30 min at 50°C, pre-denaturation for 2 min at 94°C and
PCR amplification for 38 cycles with 10 s at 94°C, 10 s at
60°C, and 30 s at 72°C. This series of cycles was followed by
melt curve analysis to check the reaction specificity. The
data was analyzed using Bio-Rad iCycler software. The ex-
pression level of each targeted gene was normalized to the
house keeping gene - GAPDH.
Statistical analysis
Data for GAGs amount in each construct at all three envi-
ronments (in vitro, in vivo, 4 and 8 weeks) were collected
from 16 samples. Values were presented as mean ± stand-
ard error of mean (SEM). ANOVA and Student’s t test
were used to compare data between groups. Differences
were considered significant when p < 0.05. Data collected
from quantitative parameter was analyzed using independ-
ent t test or Mann–Whitney test. Values were presented
as mean ± SEM. Differences at 5% level were considered
significant. All analyses were performed using SPSS 10.0
software.
Results
Cellular morphology and construct gross appearance
In monolayer culture, chondrocytes exhibited small and
polygonal shape and they continued to proliferate and
reached confluency after 1 week (Figure 3). After con-
struct implantation, all nude mice survived without any
clinical signs of morbidity or mortality. Grossly, the con-
structs demonstrated stable form of implant with no signs
of tissue reaction. After 4 and 8 weeks implantation, three
nude mice were sacrificed at 4 weeks and another three
nude mice at 8 weeks to harvest the constructs. Tissue-
engineered cartilage appeared white, smooth, glistening,Figure 3 Chondrocytes morphology at primary culture. (A) Small, poly
1 week in culture. Magnification × 200.and felt to be firm, resisting to compression resembling a
normal hyaline cartilage (Figure 4).
Histological results
The histological results at day 1 in vitro and 4 weeks
and 8 weeks in vivo constructs were variable. In vitro
samples demonstrated immature lacunae cells with
scanty basophilic matrix background. In vivo samples at
4 weeks implantation had more evenly distributed lacu-
nae cells, but immature with reactive nucleus in the tis-
sue. Samples at 8 weeks implantation revealed evenly
distributed lacunae embedded within a basophilic matrix
(Figure 5). At both 4 and 8 weeks, the tantalum remains
intact and incorporated as a composite with the cells
and fibrin.
Alcian blue staining as specific staining for proteogly-
can showed immature cells with scanty hyalinized matrix
background in in vitro samples. Following 4 weeks im-
plantation, the cells appeared rounded in clusters with
extracellular matrix-stained blue, indicating production
of proteoglycan. In vivo samples at 8 weeks demonstrated
abundant mature cells in clusters, with extensive staining
throughout the extracellular matrix (Figure 6).
GAG quantification of constructs
A mean amount of GAGs per dry weight of formed tis-
sue in in vitro, 4 weeks in vivo, and 8 weeks in vivo was
47.32 ± 3.12, 58.37 ± 1.28, and 72.40 ± 2.72, respectively
(Figure 7). Statistical analysis using ANOVA method
showed increasing amount of GAGs between groups
from in vitro (day 1) to in vivo (4 and 8 weeks) which is
significant (p < 0.005). This demonstrated high-quality
cartilage tissue formed with increasing implantation period
in the in vivo environment.
Quantitative comparison between in vitro and 4 weeks
in vivo construct using Student t test demonstrated sig-
nificant difference between the total amount of pro-
duced GAGs (p = 0.013). Comparison of total amount of
GAGs per dry weight between 4 and 8 weeks in vivogonal shape at early stage. (B) Chondrocytes reached confluency after
Figure 4 Construct of tantalum-chondrocyte-fibrin after
implantation.
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Samples at 8 weeks implantation formed more high-quality
cartilage with higher amount of GAGs production.
Immunohistochemistry of constructs
Following implantation, tissue-engineered cartilage showed
progression from immature tissues towards maturity by 4
and 8 weeks. By 8 weeks, the histological feature exhibited
lacunar being formed with increase in extracellular matrix.
In vitro construct exhibited poorly distributed cartilage cellsFigure 5 H&E staining of tissue in in vitro (A), 4 weeks in vivo (B), and
scanty basophilic background, while both in vivo constructs demonstrated ev
construct exhibited more mature cells throughout extracellular matrix.and less lacunar formed. We observed moderate expression
towards collagen type I around the underdeveloped pericel-
lular matrix but no expression for collagen type II (Figure 8).
In vivo construct showed strong expression towards
collagen type II with brown discoloration pericellular
and throughout the matrix. Weak immunopositivity was
observed towards collagen type I (Figure 9).
Real-time PCR analysis on the constructs
Cartilage-associated genes (collagen type II, aggrecan
core protein, Sox 9 transcription factor) showed signifi-
cantly higher expression in in vivo constructs at 4 and
8 weeks compared to in vitro construct. This proved the
greater ability of in vivo tissue-engineered cartilage to
produce mature cartilage phenotype. However, we observed
no significant difference between in vivo constructs at 4
and 8 weeks, except for aggrecan core protein (Figure 10).
Fibrocartilage (collagen type I) and hypertrophic (col-
lagen type X) markers showed moderately high gene ex-
pression levels. There was significant difference between
in vitro and in vivo constructs at 4 and 8 weeks but no
difference was observed between in vivo constructs at
the same period (Figure 11).
Discussion
Areas of research regarding cartilage repair have essentially
focused on cultured cells supported in the engineered tissue.
The delivery of this tissue is one of the challenges which8 weeks in vivo (C). In vitro construct showed immature cells with
enly distributed lacunae cells within basophilic matrix. However, 8-week
Figure 6 Alcian blue staining for proteoglycan of tissue in vitro (A), 4 weeks in vivo (B), and 8 weeks in vivo (C). Formed tissue obtained
from 8 weeks in vivo construct revealed abundant cells in clusters with positive staining throughout the extracellular matrix compared to 4 weeks
in vivo and in vitro construct.
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provide matrix for the cells to grow. The term ‘chondrocon-
ductive’ was described by Gordon et al. and defined as pro-
viding a scaffold for the growth of cartilage and supporting
structures [17]. They found that porous tantalum is chondro-
conductive in vitro in dynamic environment. The potential
of porous tantalum has been further evaluated by Mardones
et al. in the development of cartilage-tantalum composite
[18]. In this study, periosteum from rabbits were placed on
top of porous tantalum cylinders and cultured under chon-
drogenic conditions for 6 weeks. The findings show hyaline-
like cartilage on the surface of the cylinders while the pores
of the scaffold were filled with fibrous fixation. Mechanical
testing was also performed which showed properties similarFigure 7 Comparison of mean of GAGs amount in various environme
construct at 4 and 8 weeks. (p < 0.05).to normal rabbit cartilage. This cartilage from femoral con-
dyles were made into osteochondral plugs and tested against
the composite. It showed a stress–strain curve with charac-
teristics typical of normal cartilage responding to a load.
These findings have been the basis of further studies to con-
sider cartilage-tantalum composite as an option for resur-
facing and arthroplasty procedures. The abovementioned
technique has limitation in term of making different thick-
ness of cartilage from periosteum tissue. In the present study,
we used fibrin to bind cultured chondrocytes and seeded
onto tantalum in order to increase the feasibility of making
various thickness of cartilage tissue.
The limitation of the study was the relatively short study
period. An animal study by Shao et al. using allogeneicnts (μg/ml/mg) in increasing pattern from in vitro to in vivo
Figure 8 Immunohistochemical staining for in vitro construct shows brownish deposition for localization of collagen type I (A) but no
expression for collagen type II (B).
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onto fibrin glue matrix and medical-grade polycaprolatone
(mPCL) revealed deterioration of the transplant after
6 months, despite early good results [19]. Admittedly, if
the present study could have been conducted over the
same time period with the previous reported study, we
could have compared it better. Furthermore, the subcuta-
neous environment of our construct on the dorsum of
nude mice might not be representative of a true clinical
situation where intraarticular environment is involved.
Mrosek et al. reported an in vivo study where cylindrical
osteochondral defects were created on the medial and lat-
eral condyles of ten rabbits and filled with tantalum/perios-
teum or poly-epsilon-caprolactone/periosteum biosynthetic
composites [20]. Even though subchondral bone regener-
ation was excellent, neo-cartilage formation from periosteum
supported by a scaffold was inconsistent [20]. However,
Munirah et al. proved that autologous chondrocyte-fibrin
construct (ACFC) promotes early chondrogenesis by indu-
cing hyaline-like cartilage regeneration at 12 weeks post-
surgery in a sheep model [16]. Biomechanical testing is also
appropriate as the next step for tantalum-chondrocyte-fibrin
composite.
In the present study, the tissue-engineered cartilage
showed morphological features of polygonal that becameFigure 9 Immunohistochemical staining of in vivo construct shows st
collagen type I with brown discoloration extracellularly (B).spindle-shaped and elongated during monolayer culture.
These findings are similar to previous studies, which
portrays the dedifferentiation in culture as the cultured
chondrocytes lost their phenotype to adopt fibroblastic
traits [15,21,22]. Our 2-month results also demonstrated
that cultured chondrocytes within the fibrin and tantalum
scaffold are able to differentiate and produce hyaline-like
cartilage tissue. Histological evaluation of in vivo samples
revealed chondroblast and chondrocytes surrounded by
matrix containing hyaline. Seeded cell on tantalum in vitro
was uniform and homogenous and contained immature
chondrocytes with low concentration of GAGs in the hya-
linized matrix, while in implanted constructs, the total
amount of GAGs per dry weight of tissue significantly in-
creased. This was further proven by strong immunopositivity
by immunohistochemistry at 4 and 8 weeks, respectively. It
also means that by 2 months, the cartilage has not featured
any age-related changes yet. Studies with longer duration
need to be done to evaluate the integrity of the cartilage. We
also found that cartilage-associated genes (collagen type II,
AggC, Sox 9) showed high gene expression after 8 weeks.
This supports our hypothesis and suggested that the cartil-
age composite had produced a good matrix for the chon-
drocytes to differentiate. Similar findings were reported by
previous studies of human articular chondrocytes [15,23].rong reaction towards collagen type II (A) but weak reaction with
Figure 10 Comparison between in vivo constructs (4 and 8 weeks) to
in vitro for the quantitative RT-PCR analysis (p<0.05). It determined
the gene expression of collagen type II (A), aggrecan (B), and Sox 9 (C).
Native isolated RNA from normal native cartilage.
Figure 11 Comparison between in vivo constructs (4 and 8 weeks)
to in vitro for the quantitative RT-PCR analysis (p< 0.05) of gene
expression of collagen type I (A) and collagen type X (B). Native
isolated RNA from normal native cartilage.
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present showed much lower expression level. Sasano et al.
also discovered that chondrocytes synthesize collagen type
I and accumulate the protein in the matrix during his
study of rat tibial articular cartilage [15,24].
These findings are in accordance with previous studies
in proving that autologous chondrocyte and fibrin compos-
ite produced good-quality cartilage-like tissue [21,25-32]. In
addition, we overcome the concern of fibrin glue detach-
ment and degradation by providing a good scaffold with
tantalum. Tantalum usage has been well established in
clinical settings due to its biocompatibility and highly in-
terconnected porosity which permits physiologic bone
ingrowth and healing [17,33-41]. By 8 weeks, this tantalum-
chondrocyte-fibrin composite show good promise in pro-
viding solution for cartilage defect. Clinically, this cartilage
construct may be implanted arthroscopically and remain in
situ with a stable scaffold. This advantage offers the optionof a single surgery without the use of a periosteal patch
which can be unstable.
Conclusion
We showed that tantalum scaffold with fibrin as cell carrier
promotes cellular proliferation and cartilaginous tissue
ormation of rabbit articular chondrocytes. Engineered car-
tilage resulted from in vivo-implanted construct demon-
strated high-quality hyaline-like tissue by histological and
biochemical assessment, GAG quantification, immunohis-
tochemistry, and real-time PCR. This early results highlight
the potential of tantalum-chondrocyte-fibrin composite in
treatment of cartilage defect.
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